Advisory Services Network’s Grace Therapeutics GRCE Stock Holding History

Advisory Services Network’s Portfolio GRCE Stock Details GRCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-41	Closed	-$118	–	3742
2023 Q4	$118	Buy	+41	New	+$97	﹤0.01%	3769
2023 Q2	–	Sell	-42	Closed	-$115	–	3746
2023 Q1	$115	Hold	42	–	–	﹤0.01%	3896
2022 Q4	$125	Buy	+42	New	+$124	﹤0.01%	3895
2021 Q3	–	Sell	-42	Closed	-$1K	–	3291
2021 Q2	$1K	Buy	+42	New	+$1.02K	﹤0.01%	3530
2021 Q1	–	Sell	-42	Closed	-$1K	–	3004
2020 Q4	$1K	Hold	42	–	–	﹤0.01%	3213
2020 Q3	$0	Buy	+42	New	+$1.09K	﹤0.01%	3663
2020 Q2	–	Sell	-42	Closed	-$1K	–	2805
2020 Q1	$1K	Hold	42	–	–	﹤0.01%	2961
2019 Q4	$5K	Buy	+42	New	+$4.15K	﹤0.01%	2639
2018 Q2	–	Sell	-104	Closed	-$5K	–	2722
2018 Q1	$5K	Buy	+104	New	+$5.13K	﹤0.01%	2150

Other funds holding GRCE

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Advisory Services Network's GRCE Position: Q1 2024 in Review

Advisory Services Network sold out of Grace Therapeutics (GRCE) in Q1 2024, closing a stake of 41 shares — an estimated $118 sold.

Advisory Services Network first reported a position in GRCE in Q1 2018 and held it in 9 quarters. The position peaked at $5K in Q4 2019. 10 funds tracked by Wall St. Rank hold GRCE as of Q1 2024.

Advisory Services Network reported no remaining Grace Therapeutics position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 41 Grace Therapeutics shares in Q1 2024, an estimated $118.
Advisory Services Network first reported a position in Grace Therapeutics in Q1 2018 and held it in 9 quarters.
Advisory Services Network's Grace Therapeutics position peaked at $5K in Q4 2019.
10 funds tracked by Wall St. Rank held Grace Therapeutics as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.